Not Signed In - Greater caution on anemia drugs seen after deaths
Mon, 29 Jan 2007 01:41 PM EST
... NEW YORK (Reuters) - The higher mortality risk revealed in a trial of Amgen Inc.'s Aranesp and similar anemia medicines underscores the need to restrict their use and better understand how they work, analysts and drugmakers say. ...
Related Topics
- Anemia
- Sickle Cell Anemia
- Aplastic Anemia
- Pernicious Anemia
- Iron Deficiency Anemia
- X-linked sideroblastic anemia
- Sickle Cell
- Cooley's Anemia
- Thalassemia
- Anticancer Drugs
- Neuropathy secondary to drugs
- Date Rape Drugs
- Side effects from drugs such as amphotericin B
- Kidney impairment (from drugs used to treat the condition)
- Disease-modifying anti-rheumatoid drugs
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Low white blood cell count (from drugs used to treat the condition)
- Occipital Neuralgia
- Stroke, if clots break off and travel to the brain (drugs that thin the blood such as heparin and warfarin can reduce the risk)
- General anemia
email this page
print this page
bookmark this page
feedback on this page
